| 1. |
Petersen PJ, Jacobus NV, Weiss WJ, et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother, 1999, 43(4): 738-744.
|
| 2. |
Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis, 2010, 50(2): 133-164.
|
| 3. |
Hawser SP, Bouchillon SK, Hackel M, et al. Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004-2010. Int J Antimicrob Agents, 2012, 39(6): 490-495.
|
| 4. |
Mascarello M, Papa G, Arnez ZM, et al. Acute necrotizing pancreatitis related to tigecycline. J Antimicrob Chemother, 2012, 67(5): 1296-1297.
|
| 5. |
Bonilla MF, Avery RK, Rehm SJ, et al. Extreme alkaline phosphatase elevation associated with tigecycline. J Antimicrob Chemother, 2011, 66(4): 952-953.
|
| 6. |
Pieringer H, Schmekal B, Biesenbach G, et al. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline. Ann Hematol, 2010, 89(10): 1063-1064.
|
| 7. |
孫薇, 文仲光. 替加環素致重癥藥疹 1 例. 臨床肺科雜志, 2015, 20(1): 187-188.
|
| 8. |
李昱霖, 梁志欣, 王彬, 等. 替加環素不良反應回顧性分析. 中國藥物應用與監測, 2014, 11(2): 111-114.
|
| 9. |
Prot-Labarthe S, Youdaren R, Benkerrou M, et al. Pediatric acute pancreatitis related to tigecycline. Pediatr Infect Dis J, 2010, 29(9): 890-891.
|
| 10. |
Shao QQ, Qin L, Ruan GR, et al. Tigecycline-induced drug fever and leukemoid reaction: a case report. Medicine (Baltimore), 2015, 94(45): e1869.
|
| 11. |
Hung WY, Kogelman L, Volpe G, et al. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents, 2009, 34(5): 486-489.
|
| 12. |
Okon E, Engell C, van Manen R, et al. Tigecycline-related pancreatitis: a review of spontaneous adverse event reports. Pharmacotherapy, 2013, 33(1): 63-68.
|
| 13. |
Nitsche CJ, Jamieson N, Lerch MM, et al. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol, 2010, 24(2): 143-155.
|
| 14. |
Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf, 2008, 31(10): 823-837.
|
| 15. |
Nicolau DP, Mengedoht DE, Kline JJ. Tetracycline-induced pancreatitis. Am J Gastroenterol, 1991, 86(11): 1669-1671.
|
| 16. |
Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology, 2002, 223(3): 603-613.
|
| 17. |
Hemphill MT, Jones KR. Tigecycline-induced acute pancreatitis in a cystic fibrosis patient: A case report and literature review. J Cyst Fibros, 2016, 15(1): e9-11.
|
| 18. |
Lipshitz J, Kruh J, Cheung P, et al. Tigecycline-induced pancreatitis. J Clin Gastroenterol, 2009, 43(1): 93.
|
| 19. |
晏妮, 吳勝林, 王懿睿, 等. 藥源性胰腺炎. 藥物流行病學雜志, 2011, 20(10): 541-543.
|
| 20. |
McGovern PC, Wible M, Korth-Bradley JM, et al. Pancreatitis in tigecycline Phase 3 and 4 clinical studies. J Antimicrob Chemother, 2014, 69(3): 773-778.
|
1/5
WeChat